{
    "nct_id": "NCT05686044",
    "title": "A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging, Multicenter Study of Buntanetap in Participants With Mild to Moderate Alzheimer's Disease",
    "status": "COMPLETED",
    "last_update_time": "2025-04-24",
    "description_brief": "The purpose of this study is to measure efficacy and safety of three different doses of buntanetap/Posiphen compared with placebo in participants with mild to moderate Alzheimer's disease.\n\nStudy details include:\n\nThe double-blind treatment duration will include a screening period of up to 42 days followed by 12 weeks of treatment at home.\n\nThe study duration will be 4-5 months. There will be 4 in-clinic visits and 1 phone call.",
    "description_detailed": "320 mild to moderate AD participants will be randomized to 7.5 mg, 15 mg, 30mg of buntanetap/Posiphen once daily (QD) or placebo. If they provide informed consent, they will undergo a Screening Visit, and if they are considered eligible per the inclusion and exclusion criteria, they will proceed to participate in the treatment period. Randomized participants will visit the clinic for the first-time dosing in clinic, followed by an at home dosing period of 12 weeks, with daily administration of 7.5 mg, 15 mg or 30 mg of buntanetap/Posiphen or placebo. Participants will be required to visit clinics Day 0 (baseline), 6 weeks, and 12 weeks (end-of-trial), where they will undergo study procedures that include safety assessments (AE and concomitant medication monitoring, 12-lead ECGs, clinical laboratory testing, vital signs assessments, and physical examinations) and psychometric tests (Alzheimer's Disease Assessment Scale-Cognitive Subscale 11 (ADAS-Cog11), Alzheimer's Disease Cooperative Study-Clinical Global Impression of Change (ADCS-CGIC), Alzheimer's Disease Cooperative Study-Instrumental Activities of Daily Living Scale (ADCS-ADL), Digital Symbol Substitution Test (DSST), Mini Mental State Examination (MMSE)). At the end of blood sampling, the participants will need to stay for a minimum of 1 hour of observation. After all end-of-study procedures are complete, the subject will be discharged to home. A 24-hour follow-up call will occur after all clinical visits to assess the participants current condition and if there are any additional adverse events or questions.\n\nThe study will be a 12-weeks, placebo-controlled and double-blind trial: participants, investigators and the sponsor will be blinded to the participants' treatment.\n\nQualified participants will be randomly assigned at a 1:1:1:1 ratio to one of the four treatment arms: buntanetap/Posiphen 7.5 mg, buntanetap/Posiphen 15 mg, buntanetap/Posiphen 30mg, and placebo, through an Interactive Randomization System, after a screening period of up to 42 days.\n\nADAS-Cog 11, ADCS-CGIC, ADCS-ADL, DSST, and MMSE will be assessed by clinicians who have successfully completed the requisite certifications/trainings for each assessment.\n\nOne interim analysis is planned. It will take place when 90 enrolled subjects (\\~30%) have completed the Week 6 assessments to re-assess the sample size. No interim analyses are planned for the purpose of stopping the study early for futility.",
    "phase": [
        "PHASE2",
        "PHASE3"
    ],
    "study_type": "INTERVENTIONAL",
    "primary_purpose": "TREATMENT",
    "results": {
        "participantFlowModule": {
            "groups": [
                {
                    "id": "FG000",
                    "title": "Placebo",
                    "description": "Placebo oral capsule with daily administration for a period of 12 weeks"
                },
                {
                    "id": "FG001",
                    "title": "7.5mg Buntanetap/Posiphen",
                    "description": "Buntanetap/Posiphen 7.5mg oral capsule with daily administration for a period of 12 weeks"
                },
                {
                    "id": "FG002",
                    "title": "15mg Buntanetap/Posiphen",
                    "description": "Buntanetap/Posiphen 15mg oral capsule with daily administration for a period of 12 weeks"
                },
                {
                    "id": "FG003",
                    "title": "30mg Buntanetap/Posiphen",
                    "description": "Buntanetap/Posiphen 30mg oral capsule with daily administration for a period of 12 weeks"
                }
            ],
            "periods": [
                {
                    "title": "Overall Study",
                    "milestones": [
                        {
                            "type": "STARTED",
                            "achievements": [
                                {
                                    "groupId": "FG000",
                                    "numSubjects": "89"
                                },
                                {
                                    "groupId": "FG001",
                                    "numSubjects": "88"
                                },
                                {
                                    "groupId": "FG002",
                                    "numSubjects": "87"
                                },
                                {
                                    "groupId": "FG003",
                                    "numSubjects": "87"
                                }
                            ]
                        },
                        {
                            "type": "COMPLETED",
                            "achievements": [
                                {
                                    "groupId": "FG000",
                                    "numSubjects": "82"
                                },
                                {
                                    "groupId": "FG001",
                                    "numSubjects": "84"
                                },
                                {
                                    "groupId": "FG002",
                                    "numSubjects": "80"
                                },
                                {
                                    "groupId": "FG003",
                                    "numSubjects": "79"
                                }
                            ]
                        },
                        {
                            "type": "NOT COMPLETED",
                            "achievements": [
                                {
                                    "groupId": "FG000",
                                    "numSubjects": "7"
                                },
                                {
                                    "groupId": "FG001",
                                    "numSubjects": "4"
                                },
                                {
                                    "groupId": "FG002",
                                    "numSubjects": "7"
                                },
                                {
                                    "groupId": "FG003",
                                    "numSubjects": "8"
                                }
                            ]
                        }
                    ]
                }
            ]
        },
        "baselineCharacteristicsModule": {
            "groups": [
                {
                    "id": "BG000",
                    "title": "Placebo",
                    "description": "Placebo oral capsule with daily administration for a period of 12 weeks"
                },
                {
                    "id": "BG001",
                    "title": "7.5mg Buntanetap/Posiphen",
                    "description": "Buntanetap/Posiphen 7.5mg oral capsule with daily administration for a period of 12 weeks"
                },
                {
                    "id": "BG002",
                    "title": "15mg Buntanetap/Posiphen",
                    "description": "Buntanetap/Posiphen 15mg oral capsule with daily administration for a period of 12 weeks"
                },
                {
                    "id": "BG003",
                    "title": "30mg Buntanetap/Posiphen",
                    "description": "Buntanetap/Posiphen 30mg oral capsule with daily administration for a period of 12 weeks"
                },
                {
                    "id": "BG004",
                    "title": "Total",
                    "description": "Total of all reporting groups"
                }
            ],
            "denoms": [
                {
                    "units": "Participants",
                    "counts": [
                        {
                            "groupId": "BG000",
                            "value": "89"
                        },
                        {
                            "groupId": "BG001",
                            "value": "88"
                        },
                        {
                            "groupId": "BG002",
                            "value": "87"
                        },
                        {
                            "groupId": "BG003",
                            "value": "87"
                        },
                        {
                            "groupId": "BG004",
                            "value": "351"
                        }
                    ]
                }
            ],
            "measures": [
                {
                    "title": "Age, Continuous",
                    "paramType": "MEAN",
                    "dispersionType": "STANDARD_DEVIATION",
                    "unitOfMeasure": "years",
                    "classes": [
                        {
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "73.1",
                                            "spread": "6.97"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "73.6",
                                            "spread": "7.28"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "74.7",
                                            "spread": "6.06"
                                        },
                                        {
                                            "groupId": "BG003",
                                            "value": "73.1",
                                            "spread": "6.15"
                                        },
                                        {
                                            "groupId": "BG004",
                                            "value": "73.6",
                                            "spread": "6.64"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "title": "Sex: Female, Male",
                    "paramType": "COUNT_OF_PARTICIPANTS",
                    "unitOfMeasure": "Participants",
                    "classes": [
                        {
                            "categories": [
                                {
                                    "title": "Female",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "52"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "57"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "44"
                                        },
                                        {
                                            "groupId": "BG003",
                                            "value": "57"
                                        },
                                        {
                                            "groupId": "BG004",
                                            "value": "210"
                                        }
                                    ]
                                },
                                {
                                    "title": "Male",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "37"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "31"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "43"
                                        },
                                        {
                                            "groupId": "BG003",
                                            "value": "30"
                                        },
                                        {
                                            "groupId": "BG004",
                                            "value": "141"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "title": "Ethnicity (NIH/OMB)",
                    "paramType": "COUNT_OF_PARTICIPANTS",
                    "unitOfMeasure": "Participants",
                    "classes": [
                        {
                            "categories": [
                                {
                                    "title": "Hispanic or Latino",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "36"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "33"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "32"
                                        },
                                        {
                                            "groupId": "BG003",
                                            "value": "43"
                                        },
                                        {
                                            "groupId": "BG004",
                                            "value": "144"
                                        }
                                    ]
                                },
                                {
                                    "title": "Not Hispanic or Latino",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "53"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "55"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "55"
                                        },
                                        {
                                            "groupId": "BG003",
                                            "value": "44"
                                        },
                                        {
                                            "groupId": "BG004",
                                            "value": "207"
                                        }
                                    ]
                                },
                                {
                                    "title": "Unknown or Not Reported",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "BG003",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "BG004",
                                            "value": "0"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "title": "Race (NIH/OMB)",
                    "paramType": "COUNT_OF_PARTICIPANTS",
                    "unitOfMeasure": "Participants",
                    "classes": [
                        {
                            "categories": [
                                {
                                    "title": "American Indian or Alaska Native",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "BG003",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "BG004",
                                            "value": "0"
                                        }
                                    ]
                                },
                                {
                                    "title": "Asian",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "1"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "2"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "3"
                                        },
                                        {
                                            "groupId": "BG003",
                                            "value": "1"
                                        },
                                        {
                                            "groupId": "BG004",
                                            "value": "7"
                                        }
                                    ]
                                },
                                {
                                    "title": "Native Hawaiian or Other Pacific Islander",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "1"
                                        },
                                        {
                                            "groupId": "BG003",
                                            "value": "1"
                                        },
                                        {
                                            "groupId": "BG004",
                                            "value": "2"
                                        }
                                    ]
                                },
                                {
                                    "title": "Black or African American",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "7"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "6"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "5"
                                        },
                                        {
                                            "groupId": "BG003",
                                            "value": "7"
                                        },
                                        {
                                            "groupId": "BG004",
                                            "value": "25"
                                        }
                                    ]
                                },
                                {
                                    "title": "White",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "80"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "78"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "77"
                                        },
                                        {
                                            "groupId": "BG003",
                                            "value": "77"
                                        },
                                        {
                                            "groupId": "BG004",
                                            "value": "312"
                                        }
                                    ]
                                },
                                {
                                    "title": "More than one race",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "1"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "BG003",
                                            "value": "1"
                                        },
                                        {
                                            "groupId": "BG004",
                                            "value": "2"
                                        }
                                    ]
                                },
                                {
                                    "title": "Unknown or Not Reported",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "1"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "1"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "1"
                                        },
                                        {
                                            "groupId": "BG003",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "BG004",
                                            "value": "3"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "title": "Mini-Mental State Examination (MMSE)",
                    "description": "Mini-Mental State Examination (MMSE) is a brief screening instrument used to assess cognitive function (orientation, memory, attention, ability to name objects, follow verbal/written commands, write a sentence, and copy figures). Total score ranges from 0 to 30 with a lower score indicating greater disease severity.",
                    "paramType": "MEAN",
                    "dispersionType": "STANDARD_DEVIATION",
                    "unitOfMeasure": "units on a scale",
                    "classes": [
                        {
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "20.2",
                                            "spread": "3.04"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "19.6",
                                            "spread": "3.23"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "20.0",
                                            "spread": "3.06"
                                        },
                                        {
                                            "groupId": "BG003",
                                            "value": "20.0",
                                            "spread": "2.82"
                                        },
                                        {
                                            "groupId": "BG004",
                                            "value": "20.0",
                                            "spread": "3.04"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                }
            ]
        },
        "outcomeMeasuresModule": {
            "outcomeMeasures": [
                {
                    "type": "PRIMARY",
                    "title": "Change From Baseline to Week 12 in ADAS-Cog11",
                    "description": "Alzheimer's Disease Assessment Scale-Cognitive Subscale 11 (ADAS-Cog11) measures cognitive functions and non-cognitive functions such as mood and behavior. It was designed to measure the cognitive and behavioral domains known to be affected in Alzheimer disease, including memory, language, orientation, construction, and planning of simple designs, and completed simple goal-oriented behaviors.\n\nSpecifically, the ADAS-Cog comprises ratings from 11 components: word recall, word recognition, constructional praxis, orientation, naming objects and fingers, commands, ideational praxis, remembering test instructions, spoken language, word finding, and comprehension.\n\nTotal scores range from 0-70, with higher scores indicating greater cognitive impairment.",
                    "populationDescription": "Participants with ADAS-Cog11 scores at Baseline and 12 weeks (intent-to-treat population)",
                    "reportingStatus": "POSTED",
                    "paramType": "LEAST_SQUARES_MEAN",
                    "dispersionType": "Standard Error",
                    "unitOfMeasure": "units on a scale",
                    "timeFrame": "Baseline to the end of treatment period (12 weeks)",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "Placebo",
                            "description": "Placebo oral capsule with daily administration for a period of 12 weeks"
                        },
                        {
                            "id": "OG001",
                            "title": "7.5mg Buntanetap/Posiphen",
                            "description": "Buntanetap/Posiphen 7.5mg oral capsule with daily administration for a period of 12 weeks"
                        },
                        {
                            "id": "OG002",
                            "title": "15mg Buntanetap/Posiphen",
                            "description": "Buntanetap/Posiphen 15mg oral capsule with daily administration for a period of 12 weeks"
                        },
                        {
                            "id": "OG003",
                            "title": "30mg Buntanetap/Posiphen",
                            "description": "Buntanetap/Posiphen 30mg oral capsule with daily administration for a period of 12 weeks"
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "79"
                                },
                                {
                                    "groupId": "OG001",
                                    "value": "81"
                                },
                                {
                                    "groupId": "OG002",
                                    "value": "78"
                                },
                                {
                                    "groupId": "OG003",
                                    "value": "79"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "-2.32",
                                            "spread": "0.533"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "-1.34",
                                            "spread": "0.526"
                                        },
                                        {
                                            "groupId": "OG002",
                                            "value": "-3.01",
                                            "spread": "0.534"
                                        },
                                        {
                                            "groupId": "OG003",
                                            "value": "-2.24",
                                            "spread": "0.531"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "type": "PRIMARY",
                    "title": "ADCS-CGIC at Week 12",
                    "description": "Alzheimer's Disease Cooperative Study-Clinical Global Impression of Change (ADCS-CGIC) focuses on clinicians' observations of change in the patient's cognitive, functional, and behavioral performance since the beginning of a trial. It relies on both direct examination of the patient and interview of informants.\n\nThe ADCS-CGIC measures whether the effects of active treatment are substantial enough to be detected by a skilled and experienced clinician on the basis of a clinical interview and examination. It relies on both direct examination of the patient and an interview of the study partner.\n\nA skilled and experienced clinician who is blinded to treatment assignment rates the patient on a 7-point Likert scale, ranging from 1 (marked improvement) to 7 (marked worsening). Lower scores indicate better improvement.",
                    "populationDescription": "Participants with ADCS-CGIC scores at Baseline and 12 weeks (intent-to-treat population)",
                    "reportingStatus": "POSTED",
                    "paramType": "LEAST_SQUARES_MEAN",
                    "dispersionType": "Standard Error",
                    "unitOfMeasure": "score on a scale",
                    "timeFrame": "Baseline to the end of treatment period (12 weeks)",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "Placebo",
                            "description": "Placebo oral capsule with daily administration for a period of 12 weeks"
                        },
                        {
                            "id": "OG001",
                            "title": "7.5mg Buntanetap/Posiphen",
                            "description": "Buntanetap/Posiphen 7.5mg oral capsule with daily administration for a period of 12 weeks"
                        },
                        {
                            "id": "OG002",
                            "title": "15mg Buntanetap/Posiphen",
                            "description": "Buntanetap/Posiphen 15mg oral capsule with daily administration for a period of 12 weeks"
                        },
                        {
                            "id": "OG003",
                            "title": "30mg Buntanetap/Posiphen",
                            "description": "Buntanetap/Posiphen 30mg oral capsule with daily administration for a period of 12 weeks"
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "82"
                                },
                                {
                                    "groupId": "OG001",
                                    "value": "84"
                                },
                                {
                                    "groupId": "OG002",
                                    "value": "80"
                                },
                                {
                                    "groupId": "OG003",
                                    "value": "79"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "3.58",
                                            "spread": "0.129"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "3.96",
                                            "spread": "0.128"
                                        },
                                        {
                                            "groupId": "OG002",
                                            "value": "3.61",
                                            "spread": "0.131"
                                        },
                                        {
                                            "groupId": "OG003",
                                            "value": "3.83",
                                            "spread": "0.132"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "type": "SECONDARY",
                    "title": "Change From Baseline to Week 12 in ADCS-ADL",
                    "description": "Alzheimer's Disease Cooperative Study-Instrumental Activities of Daily Living Scale (ADCS-ADL) is a 23-item inventory scale developed as a rater-administered questionnaire answered by the participant's study partner.\n\nThe ADCS-ADL measures 6 basic activities of daily living (BADL) items and 17 instrumental activities of daily living (IADL) items that provide a total score from 0-78, with a lower score indicating greater severity. Basic activities include basic self-care tasks such as feeding, mobility, toileting, bathing, grooming and dressing. Instrumental activities are more complex and vary based on cultural norms, gender roles. As such, instrumental activities tend to include a broad range of activities.\n\nCaregivers are asked to rate the degree to which their family member or loved one can perform a variety of tasks. The assessed activities provide a total score from 0-78. Participants with a lower score indicates greater severity.",
                    "populationDescription": "Participants with ADCS-ADL scores at Baseline and 12 weeks (intent-to-treat population)",
                    "reportingStatus": "POSTED",
                    "paramType": "LEAST_SQUARES_MEAN",
                    "dispersionType": "Standard Error",
                    "unitOfMeasure": "units on a scale",
                    "timeFrame": "Baseline to end of treatment period (12 weeks)",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "Placebo",
                            "description": "Placebo oral capsule with daily administration for a period of 12 weeks"
                        },
                        {
                            "id": "OG001",
                            "title": "7.5mg Buntanetap/Posiphen",
                            "description": "Buntanetap/Posiphen 7.5mg oral capsule with daily administration for a period of 12 weeks"
                        },
                        {
                            "id": "OG002",
                            "title": "15mg Buntanetap/Posiphen",
                            "description": "Buntanetap/Posiphen 15mg oral capsule with daily administration for a period of 12 weeks"
                        },
                        {
                            "id": "OG003",
                            "title": "30mg Buntanetap/Posiphen",
                            "description": "Buntanetap/Posiphen 30mg oral capsule with daily administration for a period of 12 weeks"
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "78"
                                },
                                {
                                    "groupId": "OG001",
                                    "value": "80"
                                },
                                {
                                    "groupId": "OG002",
                                    "value": "74"
                                },
                                {
                                    "groupId": "OG003",
                                    "value": "76"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "2.03",
                                            "spread": "0.811"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "-0.14",
                                            "spread": "0.806"
                                        },
                                        {
                                            "groupId": "OG002",
                                            "value": "1.71",
                                            "spread": "0.831"
                                        },
                                        {
                                            "groupId": "OG003",
                                            "value": "0.15",
                                            "spread": "0.822"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "type": "OTHER_PRE_SPECIFIED",
                    "title": "Change From Baseline to Week 12 in Plasma Biomarkers",
                    "description": "Plasma biomarkers measured:\n\nGlial fibrillary acidic protein (GFAP), Neurofilament light (NFL), TAR DNA-binding protein 43 (TDP43)",
                    "populationDescription": "Participants with analyzable plasma biomarker samples at Baseline and 12 weeks (intent-to-treat population). Plasma biomarkers were an exploratory endpoint; this analysis only included participants from the 30mg buntanetap/posiphen and placebo groups.",
                    "reportingStatus": "POSTED",
                    "paramType": "MEAN",
                    "dispersionType": "Standard Deviation",
                    "unitOfMeasure": "pg/ml",
                    "timeFrame": "Baseline to the end of treatment period (12 weeks)",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "Placebo",
                            "description": "Placebo oral capsule with daily administration for a period of 12 weeks"
                        },
                        {
                            "id": "OG001",
                            "title": "30mg Buntanetap/Posiphen",
                            "description": "Buntanetap/Posiphen 30mg oral capsule with daily administration for a period of 12 weeks"
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "71"
                                },
                                {
                                    "groupId": "OG001",
                                    "value": "70"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "title": "GFAP",
                            "denoms": [
                                {
                                    "units": "Participants",
                                    "counts": [
                                        {
                                            "groupId": "OG000",
                                            "value": "71"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "70"
                                        }
                                    ]
                                }
                            ],
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "5.5",
                                            "spread": "74.32"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "2.1",
                                            "spread": "69.44"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "NFL",
                            "denoms": [
                                {
                                    "units": "Participants",
                                    "counts": [
                                        {
                                            "groupId": "OG000",
                                            "value": "71"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "70"
                                        }
                                    ]
                                }
                            ],
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "0.4",
                                            "spread": "6.88"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "-2.5",
                                            "spread": "14.05"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "TDP43",
                            "denoms": [
                                {
                                    "units": "Participants",
                                    "counts": [
                                        {
                                            "groupId": "OG000",
                                            "value": "61"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "65"
                                        }
                                    ]
                                }
                            ],
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "-467.5",
                                            "spread": "1474"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "-985.1",
                                            "spread": "4950"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "type": "POST_HOC",
                    "title": "Change From Baseline to Week 12 in ADAS-Cog11 for Biomarker Positive Participants With Baseline MMSE Scores 21-24",
                    "description": "Change in the ADAS-Cog11 score from Baseline to the End of Trial. Alzheimer's Disease Assessment Scale-Cognitive Subscale 11 (ADAS-Cog 11) measures cognitive functions and non-cognitive functions such as mood and behavior. It was designed to measure the cognitive and behavioral domains known to be affected in Alzheimer disease, including memory, language, orientation, construction, and planning of simple designs, and completed simple goal-oriented behaviors.\n\nSpecifically, the ADAS-Cog comprises ratings from 11 components: word recall, word recognition, constructional praxis, orientation, naming objects and fingers, commands, ideational praxis, remembering test instructions, spoken language, word finding, and comprehension.\n\nTotal scores range from 0-70, with higher scores indicating greater cognitive impairment.",
                    "populationDescription": "AD biomarker positive participants (pTau217/t-Tau Ratio \u22654.2%) with Baseline MMSE Scores 21-24 and with ADAS-Cog11 scores at Baseline and 12 weeks",
                    "reportingStatus": "POSTED",
                    "paramType": "LEAST_SQUARES_MEAN",
                    "dispersionType": "Standard Error",
                    "unitOfMeasure": "units on a scale",
                    "timeFrame": "Baseline to the end of treatment period (12 weeks)",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "Placebo",
                            "description": "Placebo oral capsule with daily administration for a period of 12 weeks"
                        },
                        {
                            "id": "OG001",
                            "title": "7.5mg Buntanetap/Posiphen",
                            "description": "Buntanetap/Posiphen 7.5mg oral capsule with daily administration for a period of 12 weeks"
                        },
                        {
                            "id": "OG002",
                            "title": "15mg Buntanetap/Posiphen",
                            "description": "Buntanetap/Posiphen 15mg oral capsule with daily administration for a period of 12 weeks"
                        },
                        {
                            "id": "OG003",
                            "title": "30mg Buntanetap/Posiphen",
                            "description": "Buntanetap/Posiphen 30mg oral capsule with daily administration for a period of 12 weeks"
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "18"
                                },
                                {
                                    "groupId": "OG001",
                                    "value": "20"
                                },
                                {
                                    "groupId": "OG002",
                                    "value": "22"
                                },
                                {
                                    "groupId": "OG003",
                                    "value": "22"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "-0.26",
                                            "spread": "0.911"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "-2.19",
                                            "spread": "0.865"
                                        },
                                        {
                                            "groupId": "OG002",
                                            "value": "-2.79",
                                            "spread": "0.815"
                                        },
                                        {
                                            "groupId": "OG003",
                                            "value": "-3.32",
                                            "spread": "0.820"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                }
            ]
        },
        "adverseEventsModule": {
            "frequencyThreshold": "5",
            "timeFrame": "From consent to end of trial (up to 5 months)",
            "description": "A total of 5 participants were mistakenly randomized in the interactive response technology (IRT) system but did not meet inclusion/exclusion criteria at the time of initial treatment. Therefore, these participants did not receive study drug or placebo and were withdrawn from the study. This is the difference between enrollment/participant flow and the number of participants assessed for adverse events.",
            "eventGroups": [
                {
                    "id": "EG000",
                    "title": "Placebo",
                    "description": "Placebo oral capsule with daily administration for a period of 12 weeks",
                    "deathsNumAffected": 0,
                    "deathsNumAtRisk": 88,
                    "seriousNumAffected": 3,
                    "seriousNumAtRisk": 88,
                    "otherNumAffected": 1,
                    "otherNumAtRisk": 88
                },
                {
                    "id": "EG001",
                    "title": "7.5mg Buntanetap/Posiphen",
                    "description": "Buntanetap/Posiphen 7.5mg oral capsule with daily administration for a period of 12 weeks",
                    "deathsNumAffected": 0,
                    "deathsNumAtRisk": 86,
                    "seriousNumAffected": 0,
                    "seriousNumAtRisk": 86,
                    "otherNumAffected": 5,
                    "otherNumAtRisk": 86
                },
                {
                    "id": "EG002",
                    "title": "15mg Buntanetap/Posiphen",
                    "description": "Buntanetap/Posiphen 15mg oral capsule with daily administration for a period of 12 weeks",
                    "deathsNumAffected": 0,
                    "deathsNumAtRisk": 85,
                    "seriousNumAffected": 0,
                    "seriousNumAtRisk": 85,
                    "otherNumAffected": 1,
                    "otherNumAtRisk": 85
                },
                {
                    "id": "EG003",
                    "title": "30mg Buntanetap/Posiphen",
                    "description": "Buntanetap/Posiphen 30mg oral capsule with daily administration for a period of 12 weeks",
                    "deathsNumAffected": 0,
                    "deathsNumAtRisk": 87,
                    "seriousNumAffected": 3,
                    "seriousNumAtRisk": 87,
                    "otherNumAffected": 1,
                    "otherNumAtRisk": 87
                }
            ],
            "seriousEvents": [
                {
                    "term": "Pneumonia",
                    "organSystem": "Infections and infestations",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 88
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 86
                        },
                        {
                            "groupId": "EG002",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 85
                        },
                        {
                            "groupId": "EG003",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 87
                        }
                    ]
                },
                {
                    "term": "Urinary tract infection",
                    "organSystem": "Infections and infestations",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 88
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 86
                        },
                        {
                            "groupId": "EG002",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 85
                        },
                        {
                            "groupId": "EG003",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 87
                        }
                    ]
                },
                {
                    "term": "Osteoarthritis",
                    "organSystem": "Musculoskeletal and connective tissue disorders",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 88
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 86
                        },
                        {
                            "groupId": "EG002",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 85
                        },
                        {
                            "groupId": "EG003",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 87
                        }
                    ]
                },
                {
                    "term": "Soft tissue mass",
                    "organSystem": "Musculoskeletal and connective tissue disorders",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 88
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 86
                        },
                        {
                            "groupId": "EG002",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 85
                        },
                        {
                            "groupId": "EG003",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 87
                        }
                    ]
                },
                {
                    "term": "Cardiac failure congestive",
                    "organSystem": "Cardiac disorders",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 88
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 86
                        },
                        {
                            "groupId": "EG002",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 85
                        },
                        {
                            "groupId": "EG003",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 87
                        }
                    ]
                },
                {
                    "term": "Oesophagitis",
                    "organSystem": "Gastrointestinal disorders",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 88
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 86
                        },
                        {
                            "groupId": "EG002",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 85
                        },
                        {
                            "groupId": "EG003",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 87
                        }
                    ]
                },
                {
                    "term": "Dehydration",
                    "organSystem": "Metabolism and nutrition disorders",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 88
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 86
                        },
                        {
                            "groupId": "EG002",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 85
                        },
                        {
                            "groupId": "EG003",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 87
                        }
                    ]
                },
                {
                    "term": "Acute respiratory failure",
                    "organSystem": "Respiratory, thoracic and mediastinal disorders",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 88
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 86
                        },
                        {
                            "groupId": "EG002",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 85
                        },
                        {
                            "groupId": "EG003",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 87
                        }
                    ]
                },
                {
                    "term": "Pulmonary embolism",
                    "organSystem": "Respiratory, thoracic and mediastinal disorders",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 88
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 86
                        },
                        {
                            "groupId": "EG002",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 85
                        },
                        {
                            "groupId": "EG003",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 87
                        }
                    ]
                }
            ],
            "otherEvents": [
                {
                    "term": "Dizziness",
                    "organSystem": "Nervous system disorders",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 88
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 6,
                            "numAffected": 5,
                            "numAtRisk": 86
                        },
                        {
                            "groupId": "EG002",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 85
                        },
                        {
                            "groupId": "EG003",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 87
                        }
                    ]
                }
            ]
        },
        "moreInfoModule": {
            "certainAgreement": {
                "piSponsorEmployee": false,
                "restrictionType": "OTHER",
                "restrictiveAgreement": true,
                "otherDetails": "The terms and conditions of Annovis Bio's agreements with its investigators may vary. However, Annovis Bio does not prohibit any investigator from publishing. Any publications from a single site are postponed until the publication of the pooled data for a clinical trial or for 12 months."
            },
            "pointOfContact": {
                "title": "Matthew Peterson, PhD",
                "organization": "Annovis Bio, Inc.",
                "email": "peterson@annovisbio.com",
                "phone": "484-875-3192"
            }
        }
    },
    "target_category": "disease-targeted small molecule",
    "drug": [
        "buntanetap (Posiphen, ANVS401)"
    ],
    "placebo": [
        "placebo"
    ],
    "explanation_target": [
        "Reason: The investigational product is buntanetap (also called Posiphen/ANVS401), an orally administered small molecule described as a translational inhibitor that lowers production of APP/A\u03b2 and other neurotoxic aggregating proteins (tau, \u03b1\u2011synuclein, TDP43), i.e., it targets Alzheimer\u2019s disease pathology rather than acting only as a symptomatic cognitive enhancer. \ue200cite\ue202turn1search6\ue202turn0search6\ue201",
        "Act: Trial details extracted \u2014 randomized, double\u2011blind, placebo\u2011controlled, dose\u2011ranging in mild\u2013moderate AD (doses 7.5 mg, 15 mg, 30 mg QD vs placebo; 12 weeks treatment; NCT05686044). These registry/listing and sponsor sources confirm the drug identity and trial design. \ue200cite\ue202turn1search2\ue202turn1search0\ue201",
        "Reflect: Classification check \u2014 because buntanetap/Posiphen is a small\u2011molecule translational inhibitor that aims to reduce pathological protein production (disease-modifying mechanism), the correct category is 'disease-targeted small molecule'. Multiple peer\u2011reviewed and sponsor sources describe this mechanism and the AD trial. No substantial ambiguity in the trial description that would suggest a different category. \ue200cite\ue202turn1search6\ue202turn1search4\ue201"
    ],
    "agent_type": "I) Proteostasis/Proteinopathies",
    "explanation_agent": [
        "Reason: Buntanetap (Posiphen/ANVS401) is described as an oral small\u2011molecule translational inhibitor that lowers production of APP and A\u03b2 and also reduces other aggregation\u2011prone proteins (tau, \u03b1\u2011synuclein, TDP\u201143). This mechanism acts on protein production/handling (translation suppression of disease\u2011causing proteins), which maps to proteostasis/proteinopathy processes rather than a symptomatic neurotransmitter target or a single\u2011pathway amyloid antibody approach. \ue200cite\ue202turn0search0\ue202turn0search2\ue201",
        "Act: Trial and drug details extracted \u2014 the listed study (NCT05686044) is a randomized, double\u2011blind, placebo\u2011controlled, dose\u2011ranging trial in mild\u2013moderate AD (buntanetap/Posiphen doses 7.5, 15, 30 mg QD vs placebo for 12 weeks). The drug\u2019s published and sponsor material describe its action as inhibiting translation of APP mRNA via an iron\u2011responsive element (IRE) and thereby reducing multiple neurotoxic proteins; Annovis and peer\u2011reviewed publications summarize these effects. These sources support classifying the drug as targeting proteostasis/proteinopathies. \ue200cite\ue202turn0search9\ue202turn0search1\ue202turn0search4\ue201",
        "Reflect: Classification check \u2014 although buntanetap reduces A\u03b2 (which could suggest CADRO A), its primary and more specific mechanistic description is suppression of translation of multiple aggregation\u2011prone proteins (a proteostasis/proteinopathy mechanism). Therefore the most specific CADRO match is I) Proteostasis/Proteinopathies rather than A) Amyloid beta or R) Multi\u2011target. This aligns with peer\u2011reviewed studies and sponsor summaries of the mechanism. \ue200cite\ue202turn0search0\ue202turn0search7\ue201",
        "Web search results (key sources consulted): 1) Alz Res & Therapy (2024) \u2014 Posiphen lowers APP translation via an IRE in APP mRNA and reduces APP/A\u03b2 (and notes effects on other IRE\u2011regulated proteins). \ue200cite\ue202turn0search0\ue201 2) PubMed/Translational inhibition study in APP/PS1 mice \u2014 efficacy and reduction of APP and fragments after Posiphen. \ue200cite\ue202turn0search2\ue201 3) Annovis Bio press releases and publications summarizing ANVS401 (buntanetap) mechanism and Phase II/III trial details. \ue200cite\ue202turn0search1\ue202turn0search4\ue201 4) Pharmacokinetics/clinical summary (PMC) and ALZFORUM therapeutic page summarizing Posiphen/buntanetap data and biomarker effects. \ue200cite\ue202turn0search5\ue202turn0search7\ue201",
        "Output: I) Proteostasis/Proteinopathies \u2014 Buntanetap is best classified under CADRO I because it targets protein production/handling (translation suppression) to lower multiple pathological aggregation\u2011prone proteins (APP/A\u03b2, tau, \u03b1\u2011synuclein, TDP\u201143)."
    ]
}